G protein-coupled receptor heterocomplexes in neuropsychiatric disorders

Progress in Molecular Biology and Translational Science

Volumn 117, Issue , 2013, Pages 187-205

  Moreno, José L ^a   Holloway, Terrell ^a   González Maeso, Javier ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; G protein coupled receptors; Parkinson's disease; Psychiatry; Receptor dimerization; Receptor heteromerization; Schizophrenia

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CANNABINOID 1 RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; MULTIPROTEIN COMPLEX; SEROTONIN;

ANIMAL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CENTRAL NERVOUS SYSTEM FUNCTION; CHEMICAL STRUCTURE; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; DEPRESSION; DOPAMINERGIC TRANSMISSION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; MENTAL DISEASE; METABOLISM; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

EID: 84896692452     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386931-9.00008-8     Document Type: Chapter

References (142)

1. K.L. Pierce, R.T. Premont, and R.J. Lefkowitz Seven-transmembrane receptors Nat Rev Mol Cell Biol 3 2002 639 650
2. K. Kristiansen Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function Pharmacol Ther 103 2004 21 80
3. R.J. Lefkowitz Historical review: a brief history and personal retrospective of seven-transmembrane receptors Trends Pharmacol Sci 25 2004 413 422
4. D.M. Perez The evolutionarily triumphant G-protein-coupled receptor Mol Pharmacol 63 2003 1202 1205
5. R. Fredriksson, M.C. Lagerstrom, L.G. Lundin, and H.B. Schioth The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol Pharmacol 63 2003 1256 1272
6. S.M. Foord, T.I. Bonner, R.R. Neubig, E.M. Rosser, J.P. Pin, and A.P. Davenport International Union of Pharmacology. XLVI. G protein-coupled receptor list Pharmacol Rev 57 2005 279 288
7. K.a. Kim, and M. von Zastrow Old drugs learn new tricks: insights from mammalian trace amine receptors Mol Pharmacol 60 2001 1165 1167
8. D.M. Rosenbaum, S.G. Rasmussen, and B.K. Kobilka The structure and function of G-protein-coupled receptors Nature 459 2009 356 363
9. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, and T.S. Kobilka High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 318 2007 1258 1265
10. S.G. Rasmussen, H.J. Choi, D.M. Rosenbaum, T.S. Kobilka, F.S. Thian, and P.C. Edwards Crystal structure of the human beta2 adrenergic G-protein-coupled receptor Nature 450 2007 383 387
11. D.M. Rosenbaum, C. Zhang, J.A. Lyons, R. Holl, D. Aragao, and D.H. Arlow Structure and function of an irreversible agonist-beta(2) adrenoceptor complex Nature 469 2011 236 240
12. M.R. Whorton, M.P. Bokoch, S.G. Rasmussen, B. Huang, R.N. Zare, and B. Kobilka A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein Proc Natl Acad Sci USA 104 2007 7682 7687
13. M.R. Whorton, B. Jastrzebska, P.S. Park, D. Fotiadis, A. Engel, and K. Palczewski Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer J Biol Chem 283 2008 4387 4394
14. J.F. Lopez-Gimenez, M. Canals, J.D. Pediani, and G. Milligan The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function Mol Pharmacol 71 2007 1015 1029
15. W. Guo, E. Urizar, M. Kralikova, J.C. Mobarec, L. Shi, and M. Filizola Dopamine D2 receptors form higher order oligomers at physiological expression levels EMBO J 27 2008 2293 2304
16. J.J. Fung, X. Deupi, L. Pardo, X.J. Yao, G.A. Velez-Ruiz, and B.T. Devree Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer EMBO J 28 2009 3315 3328
17. J.A. Hern, A.H. Baig, G.I. Mashanov, B. Birdsall, J.E. Corrie, and S. Lazareno Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules Proc Natl Acad Sci USA 107 2010 2693 2698
18. G. Milligan G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function Br J Pharmacol 158 2009 5 14
19. L. Prezeau, M.L. Rives, L. Comps-Agrar, D. Maurel, J. Kniazeff, and J.P. Pin Functional crosstalk between GPCRs: with or without oligomerization Curr Opin Pharmacol 10 2010 6 13
20. J. Gonzalez-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, and J.F. Lopez-Gimenez Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97
21. J.P. Vilardaga, V.O. Nikolaev, K. Lorenz, S. Ferrandon, Z. Zhuang, and M.J. Lohse Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling Nat Chem Biol 4 2008 126 131
22. E. Urizar, H. Yano, R. Kolster, C. Gales, N. Lambert, and J.A. Javitch CODA-RET reveals functional selectivity as a result of GPCR heteromerization Nat Chem Biol 7 2011 624 630
23. M. Fribourg, J.L. Moreno, T. Holloway, D. Provasi, L. Baki, and R. Mahajan Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs Cell 147 2011 1011 1023
24. J.L. Moreno, C. Muguruza, A. Umali, S. Mortillo, T. Holloway, and F. Pilar-Cuellar Identification of three residues essential for 5-HT2A-mGlu2 receptor heteromerization and its psychoactive behavioral function J Biol Chem 287 2012 44301 44319
25. L. Comps-Agrar, J. Kniazeff, L. Norskov-Lauritsen, D. Maurel, M. Gassmann, and N. Gregor The oligomeric state sets GABA(B) receptor signalling efficacy EMBO J 30 2011 2336 2349
26. K. Kaupmann, K. Huggel, J. Heid, P.J. Flor, S. Bischoff, and S.J. Mickel Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors Nature 386 1997 239 246
27. K. Kaupmann, B. Malitschek, V. Schuler, J. Heid, W. Froestl, and P. Beck GABA(B)-receptor subtypes assemble into functional heteromeric complexes Nature 396 1998 683 687
28. J.H. White, A. Wise, M.J. Main, A. Green, N.J. Fraser, and G.H. Disney Heterodimerization is required for the formation of a functional GABA(B) receptor Nature 396 1998 679 682
29. K.A. Jones, B. Borowsky, J.A. Tamm, D.A. Craig, M.M. Durkin, and M. Dai GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2 Nature 396 1998 674 679
30. M. Margeta-Mitrovic, Y.N. Jan, and L.Y. Jan A trafficking checkpoint controls GABA(B) receptor heterodimerization Neuron 27 2000 97 106
31. T. Galvez, B. Duthey, J. Kniazeff, J. Blahos, G. Rovelli, and B. Bettler Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function EMBO J 20 2001 2152 2159
32. Y. Tsuji, Y. Shimada, T. Takeshita, N. Kajimura, S. Nomura, and N. Sekiyama Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1 J Biol Chem 275 2000 28144 28151
33. D. El Moustaine, S. Granier, E. Doumazane, P. Scholler, R. Rahmeh, and P. Bron Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling Proc Natl Acad Sci USA 109 2012 16342 16347
34. M.L. Rives, C. Vol, Y. Fukazawa, N. Tinel, E. Trinquet, and M.A. Ayoub Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration EMBO J 28 2009 2195 2208
35. D. Maurel, L. Comps-Agrar, C. Brock, M.L. Rives, E. Bourrier, and M.A. Ayoub Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization Nat Methods 5 2008 561 567
36. J. Kniazeff, A.S. Bessis, D. Maurel, H. Ansanay, L. Prezeau, and J.P. Pin Closed state of both binding domains of homodimeric mGlu receptors is required for full activity Nat Struct Mol Biol 11 2004 706 713
37. J.J. Carrillo, J.F. Lopez-Gimenez, and G. Milligan Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor Mol Pharmacol 66 2004 1123 1137
38. W. Guo, L. Shi, M. Filizola, H. Weinstein, and J.A. Javitch Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation Proc Natl Acad Sci USA 102 2005 17495 17500
39. W. Guo, L. Shi, and J.A. Javitch The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer J Biol Chem 278 2003 4385 4388
40. J.R. James, M.I. Oliveira, A.M. Carmo, A. Iaboni, and S.J. Davis A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer Nat Methods 3 2006 1001 1006
41. K. Johnsson Visualizing biochemical activities in living cells Nat Chem Biol 5 2009 63 65
42. J.P. Vilardaga, L.F. Agnati, K. Fuxe, and F. Ciruela G-protein-coupled receptor heteromer dynamics J Cell Sci 123 2010 4215 4220
43. S. Dorsch, K.N. Klotz, S. Engelhardt, M.J. Lohse, and M. Bunemann Analysis of receptor oligomerization by FRAP microscopy Nat Methods 6 2009 225 230
44. J.M. Fonseca, and N.A. Lambert Instability of a class a G protein-coupled receptor oligomer interface Mol Pharmacol 75 2009 1296 1299
45. L. Albizu, J.L. Moreno, J. Gonzalez-Maeso, and S.C. Sealfon Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics CNS Neurol Disord Drug Targets 9 2010 636 650
46. K. Fuxe, D. Marcellino, A. Rivera, Z. Diaz-Cabiale, M. Filip, and B. Gago Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology Brain Res Rev 58 2008 415 452
47. K. Fuxe, D.O. Borroto-Escuela, D. Marcellino, W. Romero-Fernandez, M. Frankowska, and D. Guidolin GPCR heteromers and their allosteric receptor-receptor interactions Curr Med Chem 19 2012 356 363
48. J.L. Moreno, S.C. Sealfon, and J. Gonzalez-Maeso Group II metabotropic glutamate receptors and schizophrenia Cell Mol Life Sci 66 2009 3777 3785
49. S. Gines, J. Hillion, M. Torvinen, S. Le Crom, V. Casado, and E.I. Canela Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes Proc Natl Acad Sci USA 97 2000 8606 8611
50. S. Ferre, F. Ciruela, C. Quiroz, R. Lujan, P. Popoli, and R.A. Cunha Adenosine receptor heteromers and their integrative role in striatal function ScientificWorldJournal 7 2007 74 85
51. R. Franco, V. Casado, A. Cortes, J. Mallol, F. Ciruela, and S. Ferre G-protein-coupled receptor heteromers: function and ligand pharmacology Br J Pharmacol 153 Suppl. 1 2008 S90 S98
52. J.D. Salamone, A.M. Farrar, L. Font, V. Patel, D.E. Schlar, and E.J. Nunes Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism Behav Brain Res 201 2009 216 222
53. M. Schindler, C.A. Harris, B. Hayes, M. Papotti, and P.P. Humphrey Immunohistochemical localization of adenosine A1 receptors in human brain regions Neurosci Lett 297 2001 211 215
54. S. Ferre, G. von Euler, B. Johansson, B.B. Fredholm, and K. Fuxe Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes Proc Natl Acad Sci USA 88 1991 7238 7241
55. S. Ferre, P. Popoli, L. Gimenez-Llort, U.B. Finnman, E. Martinez, and A. Scotti de Carolis Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors Neuroreport 6 1994 73 76
56. M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, and S.R. Goldberg Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer J Biol Chem 278 2003 46741 46749
57. M. Torvinen, L.B. Kozell, K.A. Neve, L.F. Agnati, and K. Fuxe Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor J Mol Neurosci 24 2004 173 180
58. G. Navarro, M.S. Aymerich, D. Marcellino, A. Cortes, V. Casado, and J. Mallol Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors J Biol Chem 284 2009 28058 28068
59. J. Hillion, M. Canals, M. Torvinen, V. Casado, R. Scott, and A. Terasmaa Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors J Biol Chem 277 2002 18091 18097
60. F. Ciruela, J. Burgueno, V. Casado, M. Canals, D. Marcellino, and S.R. Goldberg Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors Anal Chem 76 2004 5354 5363
61. M.R. Gluck, L.A. Santana, H. Granson, and M.D. Yahr Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity J Neural Transm 111 2004 713 724
62. K. Fuxe, S. Ferre, S. Genedani, R. Franco, and L.F. Agnati Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function Physiol Behav 92 2007 210 217
63. D.L. Rosin, B.D. Hettinger, A. Lee, and J. Linden Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function Neurology 61 2003 S12 S18
64. S.N. Schiffmann, G. Fisone, R. Moresco, R.A. Cunha, and S. Ferre Adenosine A2A receptors and basal ganglia physiology Prog Neurobiol 83 2007 277 292
65. H.Y. Shen, J.E. Coelho, N. Ohtsuka, P.M. Canas, Y.J. Day, and Q.Y. Huang A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs J Neurosci 28 2008 2970 2975
66. G.B. Varty, R.A. Hodgson, A.J. Pond, M.E. Grzelak, E.M. Parker, and J.C. Hunter The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates Psychopharmacology (Berl) 200 2008 393 401
67. M. El Yacoubi, C. Ledent, M. Parmentier, J. Costentin, and J.M. Vaugeois Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy Neuroreport 12 2001 983 986
68. W. Li, S. Dai, J. An, R. Xiong, P. Li, and X. Chen Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model Exp Neurol 215 2009 69 76
69. T. Matsuya, K. Takuma, K. Sato, M. Asai, Y. Murakami, and S. Miyoshi Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model J Pharmacol Sci 103 2007 329 332
70. A. Mori, and T. Shindou Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists Neurology 61 2003 S44 S48
71. J.F. Chen, Z. Huang, J. Ma, J. Zhu, R. Moratalla, and D. Standaert A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice J Neurosci 19 1999 9192 9200
72. C. Perier, C. Marin, M. Bonastre, E. Tolosa, and E.C. Hirsch AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa Eur J Neurosci 16 2002 2236 2240
73. S. Dasgupta, S. Ferre, B. Kull, P.B. Hedlund, U.B. Finnman, and S. Ahlberg Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells Eur J Pharmacol 316 1996 325 331
74. H. Salim, S. Ferre, A. Dalal, R.A. Peterfreund, K. Fuxe, and J.D. Vincent Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells J Neurochem 74 2000 432 439
75. B. Kull, S. Ferre, G. Arslan, P. Svenningsson, K. Fuxe, and C. Owman Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors Biochem Pharmacol 58 1999 1035 1045
76. D.S. Kim, and R.D. Palmiter Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice Proc Natl Acad Sci USA 100 2003 1346 1351
77. T.N. Chase, F. Bibbiani, W. Bara-Jimenez, T. Dimitrova, and J.D. Oh-Lee Translating A2A antagonist KW6002 from animal models to parkinsonian patients Neurology 61 2003 S107 S111
78. K. Fuxe, D. Marcellino, S. Genedani, and L. Agnati Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease Mov Disord 22 2007 1990 2017
79. P. Jenner Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease Expert Opin Investig Drugs 14 2005 729 738
80. M.A. Schwarzschild, L. Agnati, K. Fuxe, J.F. Chen, and M. Morelli Targeting adenosine A2A receptors in Parkinson's disease Trends Neurosci 29 2006 647 654
81. S. Shiozaki, S. Ichikawa, J. Nakamura, S. Kitamura, K. Yamada, and Y. Kuwana Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP Psychopharmacology (Berl) 147 1999 90 95
82. W. Bara-Jimenez, A. Sherzai, T. Dimitrova, A. Favit, F. Bibbiani, and M. Gillespie Adenosine A(2A) receptor antagonist treatment of Parkinson's disease Neurology 61 2003 293 296
83. R.A. Hauser, J.P. Hubble, and D.D. Truong Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD Neurology 61 2003 297 303
84. A. Soriano, R. Ventura, A. Molero, R. Hoen, V. Casado, and A. Cortes Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers J Med Chem 52 2009 5590 5602
85. R. Rimondini, S. Ferre, S.O. Ogren, and K. Fuxe Adenosine A2A agonists: a potential new type of atypical antipsychotic Neuropsychopharmacology 17 1997 82 91
86. D. Malec, and E. Poleszak Involvement of adenosine receptors in dizocilpine-induced motor activity in mice Pharmacol Rep 58 2006 101 106
87. T.L. Sills, A. Azampanah, and P.J. Fletcher The adenosine A2A agonist CGS 21680 reverses the reduction in prepulse inhibition of the acoustic startle response induced by phencyclidine, but not by apomorphine and amphetamine Psychopharmacology (Berl) 156 2001 187 193
88. S. Ferre Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia Psychopharmacology (Berl) 133 1997 107 120
89. K. Fuxe, M.F. Celani, M. Martire, I. Zini, M. Zoli, and L.F. Agnati L-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes Eur J Pharmacol 100 1984 127 130
90. S. Ferre, P. Popoli, R. Rimondini, R. Reggio, J. Kehr, and K. Fuxe Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum Neuropharmacology 38 1999 129 140
91. K. Fuxe, L.F. Agnati, K. Jacobsen, J. Hillion, M. Canals, and M. Torvinen Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease Neurology 61 2003 S19 S23
92. R.J. Rodrigues, T.M. Alfaro, N. Rebola, C.R. Oliveira, and R.A. Cunha Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum J Neurochem 92 2005 433 441
93. S. Ferre, M. Karcz-Kubicha, B.T. Hope, P. Popoli, J. Burgueno, and M.A. Gutierrez Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function Proc Natl Acad Sci USA 99 2002 11940 11945
94. Z. Diaz-Cabiale, M. Vivo, A. Del Arco, W.T. O'Connor, M.K. Harte, and C.E. Muller Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors Neurosci Lett 324 2002 154 158
95. C.W. Lindsley, and C.R. Hopkins Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature Expert Opin Ther Pat 22 2012 461 481
96. A. Kachroo, L.R. Orlando, D.K. Grandy, J.F. Chen, A.B. Young, and M.A. Schwarzschild Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice J Neurosci 25 2005 10414 10419
97. R. Coccurello, N. Breysse, and M. Amalric Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats Neuropsychopharmacology 29 2004 1451 1461
98. N. Cabello, J. Gandia, D.C. Bertarelli, M. Watanabe, C. Lluis, and R. Franco Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells J Neurochem 109 2009 1497 1507
99. P. Popoli, A. Pezzola, M. Torvinen, R. Reggio, A. Pintor, and L. Scarchilli The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors Neuropsychopharmacology 25 2001 505 513
100. A. Nishi, F. Liu, S. Matsuyama, M. Hamada, H. Higashi, and A.C. Nairn Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling Proc Natl Acad Sci USA 100 2003 1322 1327
101. M.J. Marino, O. Valenti, and P.J. Conn Glutamate receptors and Parkinson's disease: opportunities for intervention Drugs Aging 20 2003 377 397
102. J. Xu, J. He, A.M. Castleberry, S. Balasubramanian, A.G. Lau, and R.A. Hall Heterodimerization of alpha 2A- and beta 1-adrenergic receptors J Biol Chem 278 2003 10770 10777
103. J.C. Ashton, I. Appleton, C.L. Darlington, and P.F. Smith Immunohistochemical localization of cerebrovascular cannabinoid CB1 receptor protein J Cardiovasc Pharmacol 44 2004 517 519
104. C. Benito, W.K. Kim, I. Chavarria, C.J. Hillard, K. Mackie, and R.M. Tolon A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis J Neurosci 25 2005 2530 2536
105. A.G. Hohmann, and M. Herkenham Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study Neuroscience 90 1999 923 931
106. T.H. Smith, L.J. Sim-Selley, and D.E. Selley Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? Br J Pharmacol 160 2010 454 466
107. T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, and G. Marsicano The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis J Biol Chem 282 2007 23892 23898
108. M.T. Tebano, A. Martire, V. Chiodi, R. Pepponi, A. Ferrante, and M.R. Domenici Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum J Neurochem 110 2009 1921 1930
109. V.M. Pickel, J. Chan, C.S. Kearn, and K. Mackie Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens J Comp Neurol 495 2006 299 313
110. H.H. Yin, and D.M. Lovinger Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling Proc Natl Acad Sci USA 103 2006 8251 8256
111. M.D. Julian, A.B. Martin, B. Cuellar, F. Rodriguez De Fonseca, M. Navarro, and R. Moratalla Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia Neuroscience 119 2003 309 318
112. F.R. Fusco, A. Martorana, C. Giampa, Z. De March, D. Farini, and V. D'Angelo Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study Synapse 53 2004 159 167
113. A. Kofalvi, R.J. Rodrigues, C. Ledent, K. Mackie, E.S. Vizi, and R.A. Cunha Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis J Neurosci 25 2005 2874 2884
114. F. Matyas, Y. Yanovsky, K. Mackie, W. Kelsch, U. Misgeld, and T.F. Freund Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia Neuroscience 137 2006 337 361
115. P. Carriba, O. Ortiz, K. Patkar, Z. Justinova, J. Stroik, and A. Themann Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids Neuropsychopharmacology 32 2007 2249 2259
116. G. Soria, A. Castane, F. Berrendero, C. Ledent, M. Parmentier, and R. Maldonado Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC Eur J Neurosci 20 2004 2203 2213
117. J.P. Meschler, and A.C. Howlett Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum Neuropharmacology 40 2001 918 926
118. A. Jarrahian, V.J. Watts, and E.L. Barker D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor J Pharmacol Exp Ther 308 2004 880 886
119. A.B. Martin, E. Fernandez-Espejo, B. Ferrer, M.A. Gorriti, A. Bilbao, and M. Navarro Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors Neuropsychopharmacology 33 2008 1667 1679
120. C.S. Kearn, K. Blake-Palmer, E. Daniel, K. Mackie, and M. Glass Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67 2005 1697 1704
121. D. Marcellino, P. Carriba, M. Filip, A. Borgkvist, M. Frankowska, and I. Bellido Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis Neuropharmacology 54 2008 815 823
122. S. Ferre, S.R. Goldberg, C. Lluis, and R. Franco Looking for the role of cannabinoid receptor heteromers in striatal function Neuropharmacology 56 Suppl. 1 2009 226 234
123. G. Navarro, P. Carriba, J. Gandia, F. Ciruela, V. Casado, and A. Cortes Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer ScientificWorldJournal 8 2008 1088 1097
124. P. Carriba, G. Navarro, F. Ciruela, S. Ferre, V. Casado, and L. Agnati Detection of heteromerization of more than two proteins by sequential BRET-FRET Nat Methods 5 2008 727 733
125. T.K. Kerppola Bimolecular fluorescence complementation: visualization of molecular interactions in living cells Methods Cell Biol 85 2008 431 470
126. J. Deckert, M. Brenner, N. Durany, R. Zochling, W. Paulus, and G. Ransmayr Up-regulation of striatal adenosine A(2A) receptors in schizophrenia Neuroreport 14 2003 313 316
127. O. Guillin, A. Abi-Dargham, and M. Laruelle Neurobiology of dopamine in schizophrenia Int Rev Neurobiol 78 2007 1 39
128. B. Dean, S. Sundram, R. Bradbury, E. Scarr, and D. Copolov Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use Neuroscience 103 2001 9 15
129. S. Sundram, D. Copolov, and B. Dean Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens Naunyn Schmiedebergs Arch Pharmacol 371 2005 428 433
130. L. Uriguen, M.J. Garcia-Fuster, L.F. Callado, B. Morentin, R. La Harpe, and V. Casado Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment Psychopharmacology (Berl) 206 2009 313 324
131. C. Kriegebaum, L. Gutknecht, A. Schmitt, K.P. Lesch, and A. Reif Serotonin now: part 1. Neurobiology and developmental genetics Fortschr Neurol Psychiatr 78 2010 319 331
132. D.E. Nichols, and C.D. Nichols Serotonin receptors Chem Rev 108 2008 1614 1641
133. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu Rev Neurosci 17 1994 31 108
134. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu Rev Pharmacol Toxicol 37 1997 205 237
135. E.E. Benarroch Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease Neurology 70 2008 964 968
136. D.D. Schoepp, and P.J. Conn Metabotropic glutamate receptors Pharmacol Biochem Behav 74 2002 255 256
137. H. Jingami, S. Nakanishi, and K. Morikawa Structure of the metabotropic glutamate receptor Curr Opin Neurobiol 13 2003 271 278
138. F. Ferraguti, and R. Shigemoto Metabotropic glutamate receptors Cell Tissue Res 326 2006 483 504
139. J. Gonzalez-Maeso, T. Yuen, B.J. Ebersole, E. Wurmbach, A. Lira, and M. Zhou Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex J Neurosci 23 2003 8836 8843
140. J. Gonzalez-Maeso, N.V. Weisstaub, M. Zhou, P. Chan, L. Ivic, and R. Ang Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452
141. J.L. Moreno, T. Holloway, L. Albizu, S.C. Sealfon, and J. Gonzalez-Maeso Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists Neurosci Lett 493 2011 76 79
142. C. Muguruza, J.L. Moreno, A. Umali, L.F. Callado, J.J. Meana, and J. Gonzalez-Maeso Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects Eur Neuropsychopharmacol 2012 10.1016/j.euroneuro. 2012.10.006 [Epub ahead of print]